These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1097150)

  • 1. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic mechanisms of bupicomide- and hydralazine-induced increase in plasma renin activity in hypertensive patients.
    Velasco M; McNay JL
    Mayo Clin Proc; 1977 Jul; 52(7):430-2. PubMed ID: 875465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.
    Chrysant SG; Adamopoulos P; Tsuchiya M; Frohlich ED
    Am Heart J; 1976 Sep; 92(3):335-9. PubMed ID: 782220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular hemodynamic interactions between clonidine and minoxidil in hypertensive patients.
    Velasco M; Silva H; Morillo J; Urbina-Quintana A; Hernandez-Pieretti O; Angeli-Greaves M
    Chest; 1983 Feb; 83(2 Suppl):360-4. PubMed ID: 6337028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
    Moskowitz RM; Cohn JN
    Clin Pharmacol Ther; 1980 Jun; 27(6):773-8. PubMed ID: 7379444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of fusaric acid on urinary excretion of catecholamines: a clinical study with particular emphasis on the characteristics of its time-course change.
    Ozawa N
    Jpn Circ J; 1972 Nov; 36(11):1205-21. PubMed ID: 4678992
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of fusaric acid and its derivative on the cardiovascular system].
    Furuta Y; Washizaki M
    Nihon Yakurigaku Zasshi; 1976 Mar; 72(2):139-44. PubMed ID: 987962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.
    Hidaka H; Takeya K
    Nature; 1972 Oct; 239(5371):334-5. PubMed ID: 12635227
    [No Abstract]   [Full Text] [Related]  

  • 12. Observation on the mechanism of renin release by hydralazine in hypertensive patients.
    Ueda H; Kaneko Y; Takeda T; Ikeda T; Yagi S
    Circ Res; 1970 Oct; 27():Suppl 2:201-6. PubMed ID: 4918551
    [No Abstract]   [Full Text] [Related]  

  • 13. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and vascular activity of LY127210, a new vasodilator, in anesthetized spontaneously hypertensive rats: comparison with hydralazine.
    Steinberg MI; Keller CE; Bemis KG
    Clin Exp Hypertens A; 1985; 7(10):1481-97. PubMed ID: 3841035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a dopamine beta-hydroxylase inhibitor on tissue catecholamine levels in spontaneously hypertensive rats subjected to immobilization-cold stress.
    Ishi Y; Homma M; Yoshikawa A
    Neuropharmacology; 1975 Feb; 14(2):155-7. PubMed ID: 1153081
    [No Abstract]   [Full Text] [Related]  

  • 19. Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.
    Carlsen JE; Jensen HA; Rehling M; Lund JO; Trap-Jensen J
    Drugs; 1988; 36 Suppl 7():55-63. PubMed ID: 3076136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of hydralazine action in hypertension.
    O'Malley K; Segal JL; Israili ZH; Boles M; McNay JL; Dayton PG
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):581-6. PubMed ID: 1102235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.